Live Price
Live Volume
NovoCure Market Segments
Overnight
*No Trades in Segment
After Hours
*No Trades in Segment
Regular Trading Hours
*No Trades in Segment
Premarket
*No Trades in Segment
After Hours Yesterday
| Open | $15.95 |
|---|---|
| Close | $15.95 |
| Low | $15.95 |
| Low Change | 0.00 (0.00%) |
| High | $15.95 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 790.277K |
| Dollar Volume | $12.60M |
Regular Trading Hours Yesterday
| Open | $16.01 |
|---|---|
| Close | $15.93 |
| Low | $15.73 |
| Low Change | -0.28 (-1.75%) |
| High | $16.10 |
| High Change | +0.09 (+0.53%) |
| Range | $0.37 |
| Volume | 1.059M |
| Dollar Volume | $16.87M |
Premarket Yesterday
| Open | $15.95 |
|---|---|
| Close | $15.91 |
| Low | $15.79 |
| Low Change | -0.16 (-1.00%) |
| High | $16.08 |
| High Change | +0.13 (+0.82%) |
| Range | $0.29 |
| Volume | 3.06K |
| Dollar Volume | $48.68K |
NovoCure News
2 months agoinvesting.comTop U.S. trending stocks: NovoCure leads with 23.4% surge
- 4 months agoinvesting.com
FreeCast surges premarket; Accenture, Novocure slide
- 4 months agoinvesting.com
Why is Novocure stock plummeting today?
- 4 months agoinvesting.com
Novocure stock tumbles after trial misses primary endpoint
- 6 months agoinvesting.com
Novocure stock rises on positive pancreatic cancer trial data
- 7 months agoinvesting.com
Novocure stock jumps after Medicare billing restored
8 months agobenzinga.comStock Market Today: Dow Jones, S&P 500 Futures Gain After Strong Job Report—Micron, Novocure, Fastly In Focus
- 8 months agoinvesting.com
Novocure shares surge after FDA approves pancreatic cancer device
- 8 months agobenzinga.com
NovoCure (NVCR) Stock Is Trending Overnight — Here's What You Should Know
- 8 months agoinvesting.com
Novocure shares soar 30% after FDA nod for pancreatic cancer device
NovoCure Top Trades
We are still processing the top long and short trades for today. Please refresh the page in 10 minutes or sign up for Finsuba Premium for real time trade insights.
NovoCure Moving Averages
| 5 Day Moving Average (SMA5) | $15.96 |
|---|---|
| 10 Day Moving Average (SMA10) | $16.26 |
| 20 Day Moving Average (SMA20) | $16.40 |
| 50 Day Moving Average (SMA50) | $16.75 |
| 100 Day Moving Average (SMA100) | $16.74 |
| 200 Day Moving Average (SMA200) | $14.69 |
NovoCure Statistics
| Average Volume (30 Days) | 1.17M |
|---|---|
| P/E Ratio (Current) | -12.49 |
| EPS (Current) | -$1.28 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$25.43M |
| Cash Ratio | 0.42 |
| Current Ratio | 2.89 |
| Quick Ratio | 2.70 |
| Debt to Equity | 0.58 |
| Enterprise Value | $1.96B |
| EV to EBITDA | -14.22 |
| EV to Sales | 2.81 |
| Price to Book | 5.51 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | 2.66 |
| Return on Assets | -0.19% |
| Return on Equity | -0.44% |
NovoCure Stock Splits
There have been no stock splits for NovoCure (NVCR).
NovoCure Dividends
There have been no dividends for NovoCure (NVCR).